[Federal Register: December 5, 2006 (Volume 71, Number 233)]
[Notices]
[Page 70516-70517]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr05de06-35]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-07-0600]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call
the CDC Reports Clearance Officer at (404) 639-5960 or send an e-mail
to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of
Management and Budget, Washington, DC or by fax to (202) 395-6974.
Written comments should be received within 30 days of this notice.
Proposed Project
Performance Evaluation Program for Mycobacterium Tuberculosis and
Non-Tuberculous Mycobacterium (NTM) Drug Susceptibility Testing (0920-
[[Page 70517]]
0600)--Extension--National Center for Health Marketing (NCHM),
Coordinating Center for Health Information and Service (COCHIS),
Centers for Disease Control and Prevention.
Background and Brief Description
While the overall number of cases of TB in the U.S. has decreased,
rates still remain high among foreign-born persons, prisoners, homeless
populations, and individuals infected with HIV in major metropolitan
areas. The rate of TB cases detected in foreign-born persons has been
reported to be almost nine times higher than the rate among the U.S.
born population. CDC's goal to eliminate TB will be virtually
impossible without considerable effort in assisting heavy disease
burden countries in the reduction of tuberculosis. As part of the
continuing effort to support both domestic and global public health
objectives for treatment of tuberculosis (TB), prevention of multi-drug
resistance and surveillance programs, the National Center for Health
Marketing, Division of Laboratory Systems (DLS) seeks to continue to
collect information from domestic private clinical and public health
laboratories twice per year. Participation and information collections
from international laboratories are limited to those which have public
health responsibilities for tuberculosis drug susceptibility testing
and approval by their national tuberculosis program. The M.
tuberculosis/NTM program supports this role by monitoring the level of
performance and practices among laboratories performing M. tuberculosis
susceptibility within the U.S. as well as internationally to promote
high-quality laboratory testing, resulting in accurate and reliable
results.
Information collected in this program includes the susceptibility
test results of primary and secondary drugs, concentrations, and test
methods performed by laboratories on a set of challenge isolates sent
twice yearly. A portion of the response instrument collects demographic
data such as laboratory type and the number of tests performed
annually. By providing an evaluation program to assess the ability of
the laboratories to test for drug resistant M. tuberculosis and
selected strains of NTM, laboratories have a self-assessment tool to
aid in maximizing their skills in susceptibility testing. Information
obtained from laboratories on susceptibility testing practices and
procedures assists with determining variables related to good
performance, with assessing areas for training and with developing
practice standards.
There are no costs to respondents other than their time. The
estimated annualized burden hours are 165.332.
Estimate of Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
Laboratories U.S. and foreign....... Enrollment............. 2 1 (5/60) 0.0833
Information change..... 2 1 (5/60) 0.0833
Results Form........... 165 2 (30/60) 0.5
----------------------------------------------------------------------------------------------------------------
Dated: November 29, 2006.
Deborah Holtzman,
Reports Clearance Officer, Centers for Disease Control and Prevention.
[FR Doc. E6-20535 Filed 12-4-06; 8:45 am]
BILLING CODE 4163-18-P